Woman Who Received Pig Kidney Along with Implanted Heart Device Dies After 47 Days

Lisa Pisano, a New Jersey woman who underwent a groundbreaking medical procedure involving a pig kidney transplant and an implanted heart pump, has sadly passed away after 47 days of complications. 

Summarized Insights:

• Lisa Pisano undergoes pig kidney transplant

• Complications arise from heart medications

• Contributions to xenotransplantation research

• Challenges and lessons for future trials

Her case, aimed at advancing xenotransplantation research, highlights both the potential and challenges of using animal organs to alleviate the critical shortage of transplantable human organs.

Lisa Pisano was near death from kidney and heart failure when surgeons at NYU Langone Health undertook the complex surgeries in April. 

Initially, her condition seemed to improve following the dual procedures, which involved not only a pig kidney transplant but also the insertion of an implanted device to assist her heart function.

However, approximately 47 days later, complications arose when her heart medications began to damage the pig kidney. 

As a result, doctors had to remove the kidney and place Pisano back on dialysis. 

Despite efforts to stabilize her condition with dialysis and the implanted heart pump, Pisano's health continued to deteriorate, eventually leading to her entering hospice care, where she passed away.

Dr. Robert Montgomery, the transplant surgeon at NYU Langone Health, praised Pisano for her bravery in participating in the experimental procedure. 

He emphasized that Pisano's willingness to undergo such pioneering treatment contributed significantly to advancing medical knowledge in xenotransplantation.

"Lisa helped bring us closer to realizing a future where someone does not have to die for another person to live," Montgomery stated in a tribute to Pisano's courage and contribution to medical science.

Lisa Pisano was the second person ever to receive a kidney from a gene-edited pig as part of ongoing efforts to develop organs that are less likely to be rejected by recipients' immune systems. 

The first recipient, Richard "Rick" Slayman, received a similar transplant but passed away nearly two months later due to preexisting heart disease unrelated to the transplant.

Xenotransplantation remains a promising avenue for addressing the critical shortage of organs for transplantation. 

With over 100,000 people currently on the U.S. transplant waiting list, most of whom require kidneys, the need for viable alternatives is urgent. 

Biotech companies are actively involved in genetically modifying pigs to make their organs more compatible with human recipients, aiming to overcome immune rejection issues.

While the outcomes of Lisa Pisano and Richard Slayman underscore the challenges and risks associated with xenotransplantation, they also provide valuable insights for future research and clinical trials. 

The lessons learned from these pioneering cases, coupled with ongoing research advancements, offer hope for improving outcomes and expanding the potential pool of transplantable organs.

As medical science continues to push boundaries in organ transplantation, the contributions of individuals like Lisa Pisano serve as poignant reminders of the courage and determination required to advance medical frontiers in the quest to save lives.